Leukemia free survival (LFS) of patients transplanted for AML in CR1. Thin lines represent the patients who had standard prognosis cytogenetics, whereas the thick lines represent patients who had poor prognosis cytogenetics. AlloBMT, allogeneic bone marrow transplantation; ABMT, autologous bone marrow transplantation. In patients with a standard prognosis karyotype, the 3 year LFS was better with AlloBMT than with ABMT (P = .04).